Dr. Agnes Chio, D.O

NPI: 1902055601
Total Payments
$5,531
2024 Payments
$18.43
Companies
19
Transactions
77
Medicare Patients
11
Medicare Billing
$761.20

Payment Breakdown by Category

Food & Beverage$5,521 (99.8%)
Education$10.28 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,521 76 99.8%
Education $10.28 1 0.2%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $1,318 33 $0 (2021)
GlaxoSmithKline, LLC. $671.72 7 $0 (2022)
Genentech USA, Inc. $659.19 6 $0 (2018)
Regeneron Healthcare Solutions, Inc. $371.87 3 $0 (2023)
Bayer HealthCare Pharmaceuticals Inc. $371.33 6 $0 (2018)
AbbVie, Inc. $313.10 3 $0 (2018)
Amarin Pharma Inc. $260.30 3 $0 (2018)
AstraZeneca Pharmaceuticals LP $254.02 2 $0 (2018)
Novartis Pharmaceuticals Corporation $249.99 2 $0 (2018)
Ipsen Biopharmaceuticals, Inc $239.28 2 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $18.43 1 PFIZER INC. ($18.43)
2023 $162.93 3 Regeneron Healthcare Solutions, Inc. ($125.00)
2022 $155.72 2 Regeneron Healthcare Solutions, Inc. ($125.00)
2021 $82.33 4 Novo Nordisk Inc ($37.32)
2020 $684.77 24 Novo Nordisk Inc ($684.77)
2019 $784.63 8 GlaxoSmithKline, LLC. ($238.83)
2018 $2,115 20 AbbVie, Inc. ($313.10)
2017 $1,527 15 Genentech USA, Inc. ($535.11)

All Payment Transactions

77 individual payment records from CMS Open Payments — Page 2 of 4

Date Company Product Nature Form Amount Type
06/25/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $15.24 General
Category: Diabetes
06/23/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $16.40 General
Category: Diabetes
06/15/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS, Tresiba Food and Beverage In-kind items and services $16.14 General
Category: Diabetes
05/20/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $21.55 General
Category: Diabetes
05/13/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $22.78 General
Category: Diabetes
03/11/2020 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Diabetes
02/19/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS, Tresiba Food and Beverage In-kind items and services $24.99 General
Category: Diabetes
01/16/2020 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Diabetes
01/15/2020 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $19.34 General
Category: Diabetes
12/04/2019 Novo Nordisk Inc Tresiba (Drug) Food and Beverage In-kind items and services $15.68 General
Category: Diabetes
11/20/2019 Novo Nordisk Inc Tresiba (Drug) Food and Beverage In-kind items and services $18.93 General
Category: Diabetes
08/09/2019 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $121.87 General
Category: INFLAMMATION AND IMMUNOLOGY
06/13/2019 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $118.63 General
Category: RESPIRATORY
06/10/2019 Mallinckrodt Enterprises LLC ACTHAR (Biological) Food and Beverage In-kind items and services $145.91 General
Category: AUTOIMMUNE AND RARE DISEASE
03/27/2019 OptiNose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $118.41 General
Category: Otolaryngology (Ear, Nose, Throat)
02/13/2019 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Diabetes
02/06/2019 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $120.20 General
Category: RESPIRATORY
11/29/2018 AbbVie, Inc. Food and Beverage In-kind items and services $71.76 General
11/07/2018 Novo Nordisk Inc Saxenda (Drug) Food and Beverage In-kind items and services $71.71 General
Category: Obesity
10/17/2018 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Hypertriglyceridemia
10/11/2018 Bayer HealthCare Pharmaceuticals Inc. Stivarga (Drug) Food and Beverage In-kind items and services $102.26 General
Category: Oncology
10/11/2018 Bayer HealthCare Pharmaceuticals Inc. Stivarga (Drug) Food and Beverage In-kind items and services $22.74 General
Category: Oncology
08/29/2018 Novo Nordisk Inc Saxenda (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Obesity
07/18/2018 Genentech USA, Inc. Avastin (Biological) Food and Beverage In-kind items and services $124.08 General
Category: BioOncology
07/10/2018 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $119.00 General
Category: DIABETES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2020 1 11 14 $3,318 $761.20
Total Patients
11
Total Services
14
Medicare Billing
$761.20
Procedure Codes
1

All Medicare Procedures & Services

1 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 11 14 $3,318 $761.20 22.9%

About Dr. Agnes Chio, D.O

Dr. Agnes Chio, D.O is a Family Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1902055601.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Agnes Chio, D.O has received a total of $5,531 in payments from pharmaceutical and medical device companies, with $18.43 received in 2024. These payments were reported across 77 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($5,521).

As a Medicare-enrolled provider, Chio has provided services to 11 Medicare beneficiaries, totaling 14 services with total Medicare billing of $761.20. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location New York, NY
  • Active Since 09/17/2008
  • Last Updated 12/01/2017
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1902055601

Products in Payments

  • Ozempic (Drug) $847.09
  • DUPIXENT (Biological) $371.87
  • Stivarga (Drug) $371.33
  • Saxenda (Drug) $311.17
  • Vascepa (Drug) $260.30
  • TRELEGY ELLIPTA (Drug) $240.12
  • Esbriet (Biological) $231.39
  • ACTHAR (Biological) $145.91
  • INCRUSE (Drug) $126.99
  • Onivyde (Drug) $125.01
  • ANORO ELLIPTA (Drug) $125.00
  • Cabometyx (Drug) $125.00
  • SANDOSTATIN LAR (Drug) $125.00
  • Victoza (Drug) $125.00
  • AFINITOR (Drug) $124.99
  • FASENRA (Drug) $124.94
  • Avastin (Biological) $124.08
  • Livalo (Drug) $122.95
  • Creon (Drug) $122.60
  • Vectibix (Biological) $119.82

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in New York